epilepsy Archives -

Considerable scientific progress across neurological diseases and disorders was reported at the recent 74th American Academy of Neurology

Recent advances in neurological disorders

https://pharmaphorum.com/r-d/recent-advances-in-neurological-disorders/

Market Access/ News/ News

FDA clears Marinus’ Ztalmy as first drug for rare epilepsy

Phil Taylor epilepsy, ganaxolone, Marinus Pharma, rare disease, regulatory approval, Ztalmy 0 Comment

People with CDKL5 deficiency disorder (CDD) now have their first FDA-approved treatment, after the US regulator gave the

FDA clears Marinus’ Ztalmy as first drug for rare epilepsy

https://pharmaphorum.com/news/fda-clears-marinus-ztalmy-as-first-drug-for-rare-epilepsy/

Digital/ News/ News

Could Facebook monitoring predict sudden epilepsy death?

Phil Taylor digital, digital health, epilepsy, Facebook, SUDEP 0 Comment

A study has suggested people with epilepsy may show patterns of activity and behaviour on social media that

Could Facebook monitoring predict sudden epilepsy death?

https://pharmaphorum.com/news/could-facebook-monitoring-spot-sudden-epilepsy-death/

Market Access/ News/ News

Wales is first UK country to fund GW’s Epidyolex for tuberous sclerosis

Phil Taylor Epidyolex, epilepsy, GW Pharma, HEOR, Jazz Pharmaceuticals, Tuberous Sclerosis Complex, Wales 0 Comment

Patients in Wales with a rare disease that causes epilepsy will be the first in the UK to

Wales is first UK country to fund GW’s Epidyolex for tuberous sclerosis

https://pharmaphorum.com/news/wales-is-first-uk-country-to-fund-gws-epidyolex-for-tuberous-sclerosis/

Market Access/ News/ News

Drug-resistant epilepsy drug Ontozry backed by NICE

Phil Taylor Angelini Pharma, epilepsy, HEOR, NICE, Ontozry 0 Comment

NHS patients in England and Wales with drug-resistant epilepsy are in line for access to another treatment option,

Drug-resistant epilepsy drug Ontozry backed by NICE

https://pharmaphorum.com/news/drug-resistant-epilepsy-drug-ontozry-backed-by-nice/

Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

The transformation of brain implants

Jessica Hagen biomarker, epilepsy, neurology, Neurosoft, traumatic brain injury 0 Comment

Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, tells us how Neurosoft’s electrode implant aims to reduce inflammation and scar

The transformation of brain implants

https://pharmaphorum.com/r-d/the-transformation-of-brain-implants/

Market Access/ News

Jazz lifted by third EU approval for GW Pharma’s Epidyolex

Phil Taylor cannabis, Epidyolex, epilepsy, EU, GW Pharma, Jazz Pharmaceuticals, rare disease 0 Comment

GW Pharmaceuticals’ Epidyolex has been approved in the EU for a third epilepsy indication, giving a boost for

Jazz lifted by third EU approval for GW Pharma’s Epidyolex

https://pharmaphorum.com/news/jazz-lifted-by-third-eu-approval-for-gw-pharmas-epidyolex/

Digital/ News/ News

UCB backs epilepsy-focused digital heath startup Nile AI

Phil Taylor digital, digital health, epilepsy, neurology, Nile AI, UCB 0 Comment

Belgian drugmaker UCB has been steadily building its digital health expertise for several years, and that includes nurturing

UCB backs epilepsy-focused digital heath startup Nile AI

https://pharmaphorum.com/news/ucb-backs-epilepsy-focused-digital-heath-startup-nile-ai/

Digital/ News/ News

Israel’s NeuroHelp to trial AI device that predicts epileptic seizures

Richard Staines artificial intelligence, epilepsy, neurology 0 Comment

NeuroHelp, a spin-off from Israel’s Ben-Gurion University of the Negev, has developed what it claims to be the

Israel’s NeuroHelp to trial AI device that predicts epileptic seizures

https://pharmaphorum.com/news/israels-neurohelp-to-trial-ai-device-that-predicts-epileptic-seizures/

Trending

epilepsy

Login